Cangrelor Patent Expiration

Cangrelor was first introduced by Chiesi Usa Inc in its drug Kengreal on Jun 22, 2015.

Cangrelor Patents

Given below is the list of patents protecting Cangrelor, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Kengreal	US10039780	Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same	Jul 10, 2035	Chiesi
Kengreal	US9295687	Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same	Jul 10, 2035	Chiesi
Kengreal	US9439921	Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same	Jul 10, 2035	Chiesi
Kengreal	US9700575	Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same	Jul 10, 2035	Chiesi
Kengreal	US8680052	Methods of treating, reducing the incidence of, and/or preventing ischemic events	Mar 09, 2033	Chiesi
Kengreal	US9427448	Methods of treating, reducing the incidence of, and/or preventing ischemic events	Nov 10, 2030	Chiesi
Kengreal	US8759316	Maintenance of platelet inhibition during antiplatelet therapy	May 13, 2029	Chiesi
Kengreal	US9925265	Methods of treating or preventing stent thrombosis	May 13, 2029	Chiesi
Kengreal	US6130208	Formulation containing a nucleotide analogue	Jun 29, 2023 (Expired)	Chiesi
Kengreal	US6114313	Pharmaceutical compositions for freeze drying	Dec 11, 2018 (Expired)	Chiesi

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List